An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.

Clinical trial NCT07543120 · RECRUITING

Trial details

NCT number: NCT07543120
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension (HTN)

Start date: 2026-05-07
Primary completion: 2031-05-31
Enrollment: 323

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.